Stock Movers Intel Rallies, Viking Therapeutics Plunges, Home Depot Climbs
Aug 19, 2025
Intel's shares surged after SoftBank's $2 billion investment, sparking optimism despite lingering doubts about the company's future. Meanwhile, Viking Therapeutics faced a steep decline as trial results for its obesity pill discouraged investors. In contrast, Home Depot saw a rise in sales as consumers embraced smaller home improvement projects. The podcast also features insights into shifting consumer trends in the home repair market, reflecting changing priorities and seasonality in renovations.
AI Snips
Chapters
Transcript
Episode notes
Government Stake Lifts Intel Momentum
- Intel shares rallied after reports the U.S. may convert Chips Act grants into a stake and after SoftBank bought $2 billion of stock.
- The market treated potential government support and SoftBank's bet as materially positive for Intel's revival.
From Ouster Call To White House Meeting
- The story turned quickly from the president calling for the CEO's ouster to that CEO meeting at the White House and news of a potential U.S. stake in Intel.
- Those rapid events shifted sentiment and helped the stock rally despite lingering questions about the company's prospects.
Trial Side Effects Send Viking Tumbling
- Viking Therapeutics plunged after a mid-stage obesity pill trial showed high side-effect dropouts, dashing hopes to rival injectable treatments.
- Traders reacted violently, producing the stock's steepest drop in years and large short-seller paper gains.